12Suppliers
16Customers
1Debt Items
20Related Chains

Azenta, Inc. Suppliers

TickerNameConfidenceEvidence
B-MEDICAL-SYSTEMS-S-R-L B-MEDICAL-SYSTEMS-S-R-L 90% Azenta Germany GmbH entered into a definitive Sale and Purchase Agreement with Thelema relating to the entire issued share capital of B Medical Systems S.À R.L.
INTEGRATED-DNA-TECHNOLOGIES INTEGRATED-DNA-TECHNOLOGIES 90% Mr. Martin joined Danaher in 2018 in connection with its acquisition of Integrated DNA Technologies ("IDT"), a supplier of custom nucleic acids, where he served as President of the IDT business under…
UK-BIOCENTRE-LIMITED UK-BIOCENTRE-LIMITED 90% Azenta UK Ltd. acquired all the issued and outstanding share capital of UK Biocentre, a provider of sample management, sample storage and high-throughput sample processing services
MARAVAI-LIFESCIENCES-HOLDINGS-INC MARAVAI-LIFESCIENCES-HOLDINGS-INC 80% Mr. Martin most recently served as Chief Executive Officer of Maravai LifeSciences Holdings, Inc. (Nasdaq: MRVI), a life sciences company providing products and services to enable the development of …
THELEMA-S-R-L THELEMA-S-R-L 80% Thelema is a private limited liability company incorporated under the laws of Luxembourg.
MANU Manchester 72% n vector used in CGT. Furthermore, we continue to add value to drug discovery and development research by expanding our portfolio to include proteomics solutions. We will continue to focus on develop…
MANU Manchester 72% Reciprocal relationship from MANU graph: Reciprocal relationship from AZTA graph: n vector used in CGT. Furthermore, we continue to add value to drug discovery and development research by expanding o…
TMO Thermo Fisher Scientific Inc. 72% que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In the Sample Management Solutions segment, our main competitors include Hamilton Com…
TMO Thermo Fisher Scientific Inc. 72% Reciprocal relationship from TMO graph: Reciprocal relationship from AZTA graph: Reciprocal relationship from TMO graph: Reciprocal relationship from AZTA graph: Reciprocal relationship from TMO grap…
TWST Twist Bioscience Corporation 72% Reciprocal relationship from TWST graph: Reciprocal relationship from AZTA graph: Reciprocal relationship from TWST graph: Reciprocal relationship from AZTA graph: Reciprocal relationship from TWST g…
TWST Twist Bioscience Corporation 72% que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In the Sample Management Solutions segment, our main competitors include Hamilton Com…
DANAHER-CORPORATION DANAHER-CORPORATION 70% Mr. Martin was Senior Vice President, New Business—Genomic Medicine at Danaher Corporation (NYSE: DHR), a global science and technology company, from July 2021 to July 2022.

Azenta, Inc. Customers

TickerNameConfidenceEvidence
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES 95% USAspending awards from Department of Health and Human Services: $4,302 across 1 awards. 75N95020P00106 BIOSTORE III CRYO -190C CRYOGENIC STORAGE SYSTEM WITH ACCESSORIES AND A SERVICE AGREEMENT. | Qw…
B-MEDICAL-SYSTEMS-SEGMENT B-MEDICAL-SYSTEMS-SEGMENT 92% One customer accounted for 10 % and 13 % of the Company’s consolidated revenue for fiscal years 2024 and 2023 , respectively. This customer is related to the B Medical Systems segment and is a distri…
THELEMA-S-R-L THELEMA-S-R-L 92% Thelema is acquiring 100% of B Medical’s share capital for USD 63,000,000.
MANU Manchester 72% n vector used in CGT. Furthermore, we continue to add value to drug discovery and development research by expanding our portfolio to include proteomics solutions. We will continue to focus on develop…
MANU Manchester 72% Reciprocal relationship from MANU graph: Reciprocal relationship from AZTA graph: Reciprocal relationship from MANU graph: Reciprocal relationship from AZTA graph: n vector used in CGT. Furthermore, …
TMO Thermo Fisher Scientific Inc. 72% Reciprocal relationship from TMO graph: Reciprocal relationship from AZTA graph: que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In t…
TMO Thermo Fisher Scientific Inc. 72% que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In the Sample Management Solutions segment, our main competitors include Hamilton Com…
TWST Twist Bioscience Corporation 72% que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In the Sample Management Solutions segment, our main competitors include Hamilton Com…
TWST Twist Bioscience Corporation 72% Reciprocal relationship from TWST graph: Reciprocal relationship from AZTA graph: que portfolio of products and services. Each segment, however, has unique competitors in their area of offerings. In …
AMERICA-HOLDINGS AMERICA-HOLDINGS 62% ferings. In the Sample Management Solutions segment, our main competitors include Hamilton Company and Liconic AG for automation systems and Laboratory Corporation of America Holdings and Thermo Fish…
BARKEY-HOLDING-GMBH BARKEY-HOLDING-GMBH 62% Item 8, “Financial Statements and Supplementary Data” of this Annual Report on Form 10‑K. Within our Sample Management Solutions segment, we operate as a single business unit offering end-to-end samp…
BGI-GENOMICS-CO-LTD BGI-GENOMICS-CO-LTD 62% ferings. In the Sample Management Solutions segment, our main competitors include Hamilton Company and Liconic AG for automation systems and Laboratory Corporation of America Holdings and Thermo Fish…
BROOKS-AUTOMATION-INC BROOKS-AUTOMATION-INC 62% Item 1A “Risk Factors” below, as updated and/or supplemented in subsequent filings with the SEC. These and other factors could cause our future performance to differ materially from our assumptions a…
LICONIC-AG LICONIC-AG 62% ferings. In the Sample Management Solutions segment, our main competitors include Hamilton Company and Liconic AG for automation systems and Laboratory Corporation of America Holdings and Thermo Fish…
MEDICAL-SYSTEMS-HOLDINGS MEDICAL-SYSTEMS-HOLDINGS 62% s Completed in Fiscal Year 2023 Ziath Ltd On February 2, 2023, the Company acquired Ziath, Ltd. and its subsidiaries (“Ziath”). Based in Cambridge, United Kingdom, Ziath is a leading provider of 2D b…
ZIATH-LTD ZIATH-LTD 62% s Completed in Fiscal Year 2023 Ziath Ltd On February 2, 2023, the Company acquired Ziath, Ltd. and its subsidiaries (“Ziath”). Based in Cambridge, United Kingdom, Ziath is a leading provider of 2D b…

Azenta, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
AZTA-DEBT Debt stack $55.7M 90% Market cache reports total debt of $55.7M.

Azenta, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Azenta, Inc..

Azenta, Inc. Ownership

HolderNameConfidenceEvidence
AZTA-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 263 tracked holders.

Azenta, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
DOYU DouYu International Holdings Limited 100.00 2
GGB Gerdau S.A. 100.00 2
CLLS Cellectis S.A. 100.00 2
DGNX Diginex Limited 100.00 2
ICLR ICON Public Limited Company 100.00 2
UNFI United Natural Foods, Inc. 100.00 2
AAUAF Almaden Minerals Ltd. 100.00 2
BHPLF BHP Group Limited 100.00 2
BTAI BioXcel Therapeutics, Inc. 100.00 2
RYAOF Ryanair Holdings plc 100.00 2
BANL CBL International Limited 100.00 2
GVH Globavend Holdings Limited 100.00 2
CBAN Colony Bankcorp, Inc. 100.00 2
ALGM Allegro MicroSystems, Inc. 100.00 2
GRAL GRAIL, Inc. 100.00 2
ALCY Alchemy Investments Acquisition Corp 1 100.00 2
AUGO Aura Minerals Inc. 100.00 2
ACET Adicet Bio, Inc. 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
GH Guardant Health, Inc. 100.00 2